A new federal initiative under the Trump Administration is testing an artificial intelligence system to assist in evaluating and determining approval or denial of medical care requests. The program, still in its pilot phase, marks a significant shift toward leveraging AI in healthcare decision-making. Critics and advocates alike are closely watching how such technology could reshape patient access to treatments. Details on implementation and potential impacts remain under review as the program progresses.
The Trump Administration is piloting a federal program that uses artificial intelligence to help decide what care to approve or deny.
